STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...

A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled “A ...

Current methods for the determination of RNA quantity/quality/integrity are labor-intensive, costly, and often cannot deliver adequate information or analyze high numbers of samples. New developments ...

Our results demonstrate that differential connectivity analysis reveals significant transcriptional alterations that are not ...

Years of experiments and databases filled with RNA-seq results belie the simple reality that, until fairly recently, it was impossible to analyze RNA directly. The RNA-seq studies performed with ...

Researchers analyzed gene expression and network connectivity across eight human tissues and found shared aging-related ...

In advanced therapy development, blood samples are essential to gain molecular insights. RNA and biomarker profiles are highly sensitive to preanalytical variables—such as collection, transport, ...

Researchers have developed a groundbreaking microscopy method that enables detailed three-dimensional (3D) RNA analysis at cellular resolution in whole intact mouse brains. The new method, called ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools. For problems in the genitourinary (GU) tract (which includes the kidneys, ...

RNAConnect, a pioneering life science reagent company, has officially launched. The company promises groundbreaking solutions for exploring the real-world diversity of RNA sequence and structure.